Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
about
The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsiaAccuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysisA Comprehensive Review of Hypertension in PregnancyMolecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia.Relation between maternal angiogenic factors and utero-placental resistance in normal first- and second-trimester pregnancies.Non-invasive epigenetic detection of fetal trisomy 21 in first trimester maternal plasmaDifferential expression of Vegfr-2 and its soluble form in preeclampsiaThe vascular endothelial growth factor family in adverse pregnancy outcomes.Association between genetic polymorphisms in androgen receptor gene and the risk of preeclampsia in Korean womenFirst trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.Circulating angiogenic and antiangiogenic factors in women with eclampsia.Angiogenic factors and preeclampsia.Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational studyA fetal variant in the GCM1 gene is associated with pregnancy induced hypertension in a predominantly hispanic population.First-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.Anti-angiogenic assay assists fetal extraction decision in a case of pre-eclampsia suspicion?Relationships among maternal nutrient intake and placental biomarkers during the 1st trimester in low-income women.Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion.Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaGenetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: type 1 versus type 2 preeclampsia?Short- and long-term strategies for the management of hypertensive disorders of pregnancy.Aspirin for prevention of preeclampsia in lupus pregnancy.Markers of preeclampsia and the relationship to cardiovascular disease: review of the twenty-first century literature.Dynamic proteome in enigmatic preeclampsia: an account of molecular mechanisms and biomarker discovery.Clinical applications of biomarkers in preeclampsia.Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration.Accuracy of Soluble Endoglin for Diagnosis of Preeclampsia and its SeverityRacial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.Anti-angiogenesis and Preeclampsia in 2016.Using the angiogenic factors sFlt-1 and PlGF with Doppler ultrasound of the uterine artery for confirming preeclampsia.Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy.Gene expression in chorionic villous samples at 11 weeks' gestation from women destined to develop preeclampsia.Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester.
P2860
Q26798193-60E9E580-8484-4444-A12E-66CF8BAC8077Q26825271-4E53EEC6-8918-44E6-8BA4-63E4371FDAAAQ27495953-B53DDF25-3514-4B12-B64B-CBF8D438FFABQ33349894-D69CE970-A736-4C02-8701-0A025D094FE3Q33597631-CA196CE6-FA91-4E58-AFE6-43C7999D6C24Q33667332-6497B09C-FC35-4960-B183-4B5832B37BA2Q34087801-256042B0-39C4-42AB-8141-259EA2F117F4Q34201006-6F37F516-2014-4184-A7A1-DB33B907013BQ34267491-23B4FBD5-1765-44E8-8757-EBFF153086B4Q34608698-4217C88D-026A-4259-A703-7D59AC10B425Q34655258-5BA2221F-E2E5-4334-9340-DA8759B18A54Q34670638-C776B1AE-A997-4CF2-BFC4-5F3530B65BBCQ34714082-0EE8D1EC-DB9F-45C9-BC7D-5A2FC37E4F5DQ34929017-4CC0C59D-C4BC-4FE3-8CC7-15CE74486362Q35193823-A50A63F3-8527-4C54-9456-A898C776127CQ35532857-FEAA045C-B08C-4DD0-B9F6-350D45C1A462Q35574267-FDB283C6-3841-4A08-8EF6-319B92542F47Q35878707-81B7EF28-599A-46FE-9853-ADE3EDD7BC9CQ36062460-5170CB44-4BC5-407E-88CC-0774116A444DQ36107337-838D71D3-A67C-4F8F-9A0D-61C900B068D5Q36185056-ADB5AB93-7A05-4CD6-A230-B1BD0D1A7D50Q36189562-B198735D-ACA0-426D-B138-421868E0F8CCQ36268948-190EFE65-F683-455B-87FE-EB49D5C5E19CQ36626307-932586CC-DD6F-4007-8CE0-3768989E943AQ37642835-E5E8CD81-085A-42ED-BCA4-887E1327C63AQ37687986-0CFFEA0B-5C30-48A0-883B-4AD9A9CFC7CFQ37748773-EB5A860B-27BE-45BF-AAA4-9B5AD2F21C88Q37996960-9F207E19-6C2E-445E-A5F6-C570CAE19D4CQ38209381-8310D2DC-B853-4089-BBC4-DE8A6CA4D7B9Q38727068-64C3A4A1-C5C9-4E3A-8953-08A9105C9C67Q38756162-5AF130CB-8845-4813-B4AF-E6F709C1554DQ38881898-DCDD0684-AE7E-4394-BC87-597FEE145E3EQ39117000-20341C2A-9A44-4EE1-B52D-CE01C0779958Q39713672-C88CB5BB-FA0B-4D81-9928-4E8CA40A909CQ43689140-ED7521CD-16AD-479D-B134-3D35A0CBD306Q44076540-5700EEA3-E88B-45E3-8211-E8A5AE24EDE6Q45891375-99BBE4D8-3E63-43C9-A949-4685EC684A6FQ51372917-9ACF91BE-A986-4531-95E0-DFF2E301D855Q51791219-14A961A7-7952-4742-8404-D133F0053DAFQ53344481-BACCF13F-090A-43C8-95CB-3B6C6C458417
P2860
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@en
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@nl
type
label
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@en
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@nl
prefLabel
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@en
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@nl
P2093
P1476
Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
@en
P2093
Hyun Mee Ryu
Jae Hyug Yang
Moon Young Kim
Shin Young Kim
So Yeon Park
P304
P356
10.1097/AOG.0B013E3181719B7A
P407
P50
P577
2008-06-01T00:00:00Z